Abstract:Cathepsin K (Cat-K) highly expressed in osteoclasts, is considered to be a promising target for osteoclast-related maladies. In the present study, quantitative structure–activity relationships (QSAR) and molecular docking approaches were used to identify promising Cat-K inhibitors from a series of Amide-Ac6-aminoacetonitriles analogs. During the two-dimensional QSAR study, the statistical model PLS_MDL was chosen (r2 = 0.823, q2 (cross-validation) = 0.732). Descriptors with positive or negative contributions were derived from model PLS_MDL. In order to build robust three-dimensional QSAR models, three different molecular fingerprints were used as analysis precepts for clustering and three different minimization algorithms were employed for generation of molecular poses. The best database which used molecular fingerprint of FCFP and minimization algorithm of Smart Minimizer was selected for further QSAR model construction. The ideal CoMFA and CoMSIA models were acquired (CoMFA: r2 = 0.963, q2 = 0.674, r2pred = 0.702 and Q2 (F2) = 0.616; CoMSIA_SEHA: r2 = 0.989, q2 = 0.622, r2pred = 0.719 and Q2 (F2) = 0.638). Physicochemical, structural, electrostatic, and steric properties were derived from the created QSAR models and then applied to portray a design scheme. Furthermore, after a selecting of docking scheme, docking studies were carried out to measure the binding affinity of eligible query compounds and to reveal the detailed interactions between ligand and the target protein. Amongst these designed compounds, compound19OX32 was focused for its preferable predicted activity and docking score. Strong interactions and extra hydrogen bonds which echoed the previous summarized design scheme were also observed via a deep investigation of docking result. Consequently, compound 19OX32 was identified as promising Cat-K inhibitor.

Highly Selective Aza-Nitrile Inhibitors for Cathepsin K, Structural Optimization and Molecular Modeling

Structure-Based Design Of Tripeptide Derivatives Of α-Aminoalkylphosphonate Esters For Prostate-Specific Antigen Inhibition

A Combined approach of QSAR study, molecular docking and pharmacokinetics prediction of promising Amide-Ac6-aminoacetonitriles Cathepsin K inhibitors

Design and Synthesis of Arylaminoethyl Amides As Noncovalent Inhibitors of Cathepsin S. Part 1.

Design, Synthesis, and Screen of Cathepsin K Inhibitors

Discovery of Selective Covalent Cathepsin K Inhibitors Containing Novel 4-Cyanopyrimidine Warhead Based on Quantum Chemical Calculations and Binding Mode Analysis

Novel selective proline-based peptidomimetics for human cathepsin K inhibition

Inhibitors of Cathepsins K and S Identified Using the DynaMAD Virtual Screening Algorithm

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.

Design and Synthesis of Novel Cathepsin C Inhibitors with Anti-Inflammatory Activity

Design, Synthesis and Evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide Derivatives As BACE-1 Inhibitors

Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis

Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development

Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors.

Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting

An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94

Synthesis and Biological Evaluation of Novel Piperidine-3-Carboxamide Derivatives as Anti-Osteoporosis Agents Targeting Cathepsin K

3D QSAR Studies on Ketoamides of Human Cathepsin K Inhibitors Based on Two Different Alignment Methods